MSMichael A. Speidel

Michael A. Speidel

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Michael A. Speidel has a total of 69 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Hepatic Histotripsy after Contrast-Enhanced Ultrasound: Evaluation of Safety and Efficacy in an In Vivo Swine Model

    by Katrina L. Falk, Martin G. Wagner, Saryn Doucette, Tyler Schluter, Ali Mutlu, Adrienne L. Kisting, Michael A. Speidel, Gretchen M. Foltz, Timothy J. Ziemlewicz, Fred T. Lee, et al.


  • Open Access

    Technique selection and technical developments for 2D dual‐energy subtraction angiography on an interventional C‐arm

    by Ethan P. Nikolau, Joseph F. Whitehead, Martin G. Wagner, James R. Scheuermann, Paul F. Laeseke, Michael A. Speidel

    Background: Dual‐energy (DE) x‐ray image acquisition has the potential to provide material‐specific angiographic images in the interventional suite. This approach can be implemented with novel detector technologies, such as dual‐layer and photon‐counting detectors. Alternatively, DE imaging can be implemented on existing systems using fast kV‐switching. Currently, there are no commercially available DE options for interventional platforms. Purpose: This study reports on the development of a prototype fast kV‐switching DE subtraction angiography system. In contrast to alternative approaches to DE imaging in the interventional suite, this prototype uses a clinically available interventional C‐arm equipped with special x‐ray tube control software. An automatic exposure control algorithm and technical features needed for such a system in the interventional setting are developed and validated in phantom studies. Methods: Fast kV‐switching was implemented on an interventional C‐arm platform using software that enables frame‐by‐frame specification of x‐ray tube techniques (e.g., tube voltage/kV, pulse width/ms, tube current/mA). A real‐time image display was developed on a portable workstation to display DE subtraction images in real‐time (nominal 15 frame/s). An empirical CNR‐driven automatic exposure control (AEC) algorithm was created to guide DE tube technique selection (kV pair, ms pair, mA). The AEC model contained a look‐up table which related DE tube technique parameters and air kerma to iodine CNR, which was measured in acrylic phantom models containing an iodine‐equivalent reference object. For a given iodine CNR request, the AEC algorithm estimated patient thickness and then selected the DE tube technique expected to deliver the requested CNR at the minimum air kerma. The AEC algorithm was developed for DE imaging performed without and with the application of anti‐correlated noise reduction (ACNR). Validation of the AEC model was performed by comparing the AEC‐predicted iodine CNR values with directly measured values in a separate phantom study. Both dose efficiency (CNR 2 /kerma) and maximum achievable iodine CNR (within tube technique constraints) were quantified. Finally, improvements in DE iodine CNR were quantified using a novel variant to the ACNR approach, which used machine‐learning image denoising (ACNR‐ML). Results: The prototype system provided a continuous display of DE subtraction images. For standard DE imaging, the AEC‐predicted iodine CNR values agreed with directly measured values to within 3.5% ± 1.6% (mean ± standard deviation). When ACNR was applied, predicted iodine CNR agreed with measurement to within 2.1% ± 3.3%. AEC‐generated DE techniques were typically (low/high energy): 63/125 kV, 10/3.2 ms, with varying mA values. When ACNR was applied, dose efficiency was increased by a factor of 9.37 ± 2.08 and maximum CNR was increased by a factor of 3.29 ± 0.21 relative to DE without denoising. Application of ACNR‐ML yielded a greater increase in both the dose efficiency (16.11 ± 2.99) and maximum CNR (4.46 ± 0.31) compared to DE without denoising. Conclusion: A prototype DE subtraction angiography system using fast kV‐switching was implemented on a clinically available interventional C‐arm platform without modification of system hardware. The technical features presented in this work include a real‐time image display, noise‐reduction strategies, and a CNR‐driven AEC algorithm. This prototype system demonstrates the feasibility of 2D dual‐energy imaging for image‐guided interventions.


  • Quantitative 2-Dimensionsal Digital Subtraction Venography for Venous Interventions: Validation in Phantom and In Vivo Porcine Models

    by Sarvesh Periyasamy, Erick L. Oberstar, Joseph F. Whitehead, Ayca Z. Kutlu, Alexander A. Pieper, Carson A. Hoffman, Geng Li, Chris L. Brace, Michael A. Speidel, Paul F. Laeseke


  • Motion-compensation approach for quantitative digital subtraction angiography and its effect on in-vivo blood velocity measurement

    by Joseph F. Whitehead, Sarvesh Periyasamy, Paul F. Laeseke, Michael A. Speidel, Martin G. Wagner

    PurposeQuantitative monitoring of flow-altering interventions has been proposed using algorithms that quantify blood velocity from time-resolved two-dimensional angiograms. These algorithms track the movement of contrast oscillations along a vessel centerline. Vessel motion may occur relative to a statically defined vessel centerline, corrupting the blood velocity measurement. We provide a method for motion-compensated blood velocity quantification.ApproachThe motion-compensation approach utilizes a vessel segmentation algorithm to perform frame-by-frame vessel registration and creates a dynamic vessel centerline that moves with the vasculature. Performance was evaluated in-vivo through comparison with manually annotated centerlines. The method was also compared to a previous uncompensated method using best- and worst-case static centerlines chosen to minimize and maximize centerline placement accuracy. Blood velocities determined through quantitative DSA (qDSA) analysis for each centerline type were compared through linear regression analysis.ResultsCenterline distance errors were 0.3±0.1 mm relative to gold standard manual annotations. For the uncompensated approach, the best- and worst-case static centerlines had distance errors of 1.1±0.6 and 2.9±1.2 mm, respectively. Linear regression analysis found a high R-squared between qDSA-derived blood velocities using gold standard centerlines and motion-compensated centerlines (R2=0.97) with a slope of 1.15 and a small offset of −0.6 cm/s. The use of static centerlines resulted in low coefficients of determination for the best case (R2=0.35) and worst-case (R2=0.20) scenarios, with slopes close to zero.ConclusionsIn-vivo validation of motion-compensated qDSA analysis demonstrated improved velocity quantification accuracy in vessels with motion, addressing an important clinical limitation of the current qDSA algorithm.


  • Open Access

    Interleaved x‐ray imaging: A method for simultaneous acquisition of quantitative and diagnostic digital subtraction angiography

    by Joseph F. Whitehead, Carson A. Hoffman, Martin G. Wagner, Grace M. Minesinger, Ethan P. Nikolau, Paul F. Laeseke, Michael A. Speidel

    Background: Flow altering angiographic procedures suffer from ill‐defined, qualitative endpoints. Quantitative digital subtraction angiography (qDSA) is an emerging technology that aims to address this issue by providing intra‐procedural blood velocity measurements from time‐resolved, 2D angiograms. To date, qDSA has used 30 frame/s DSA imaging, which is associated with high radiation dose rate compared to clinical diagnostic DSA (up to 4 frame/s).Purpose: The purpose of this study is to demonstrate an interleaved x‐ray imaging method which decreases the radiation dose rate associated with high frame rate qDSA while simultaneously providing low frame rate diagnostic DSA images, enabling the acquisition of both datasets in a single image sequence with a single injection of contrast agent.Methods: Interleaved x‐ray imaging combines low radiation dose image frames acquired at a high rate with high radiation dose image frames acquired at a low rate. The feasibility of this approach was evaluated on an x‐ray system equipped with research prototype software for x‐ray tube control. qDSA blood velocity quantification was evaluated in a flow phantom study for two lower dose interleaving protocols (LD1: and LD2: ) and one conventional (full dose) protocol (. Dose was measured at the interventional reference point. Fluid velocities ranging from 24 to 45 cm/s were investigated. Gold standard velocities were measured using an ultrasound flow probe. Linear regression and Bland‐Altman analysis were used to compare ultrasound and qDSA.Results: The LD1 and LD2 interleaved protocols resulted in dose rate reductions of −67.7% and −85.5%, compared to the full dose qDSA scan. For the full dose protocol, the Bland‐Altman limits of agreement (LOA) between qDSA and ultrasound velocities were [0.7, 6.7] cm/s with a mean difference of 3.7 cm/s. The LD1 interleaved protocol results were similar (LOA: [0.3, 6.9] cm/s, bias: 3.6 cm/s). The LD2 interleaved protocol resulted in slightly larger LOA: [−2.5, 5.5] cm/s with a decrease in the bias: 1.5 cm/s. Linear regression analysis showed a strong correlation between ultrasound and qDSA derived velocities using the LD1 protocol, with a of , a slope of and an offset of cm/s. Similar values were also found for the LD2 protocol, with a of , a slope of and an offset of cm/s.Conclusions: The interleaved method enables simultaneous acquisition of low‐dose high‐rate images for intra‐procedural blood velocity quantification (qDSA) and high‐dose low‐rate images for vessel morphology evaluation (diagnostic DSA).


  • Three-dimensional catheter navigation of airways using continuous-sweep limited angle fluoroscopy on a C-arm

    by Martin G. Wagner, Sarvesh Periyasamy, Sebastian Schafer, Paul F. Laeseke, Michael A. Speidel

    Purpose: To develop an imaging-based 3D catheter navigation system for transbronchial procedures including biopsy and tumor ablation using a single-plane C-arm x-ray system. The proposed system provides time-resolved catheter shape and position as well as motion compensated 3D airway roadmaps. Approach: A continuous-sweep limited angle (CLA) imaging mode where the C-arm continuously rotates back and forth within a limited angular range while acquiring x-ray images was used for device tracking. The catheter reconstruction was performed using a sliding window of the most recent x-ray images, which captures information on device shape and position versus time. The catheter was reconstructed using a model-based approach and was displayed together with the 3D airway roadmap extracted from a pre-navigational cone-beam CT (CBCT). The roadmap was updated in regular intervals using deformable registration to tomosynthesis reconstructions based on the CLA images. The approach was evaluated in a porcine study (three animals) and compared to a gold standard CBCT reconstruction of the device. Results: The average 3D root mean squared distance between CLA and CBCT reconstruction of the catheter centerline was 1 ± 0.5 mm for a stationary catheter and 2.9 ± 1.1 mm for a catheter moving at ∼1 cm / s. The average tip localization error was 1.3 ± 0.7 mm and 2.7 ± 1.8 mm, respectively. Conclusions: The results indicate catheter navigation based on the proposed single plane C-arm imaging technique is feasible with reconstruction errors similar to the diameter of a typical ablation catheter.


  • Technical and clinical study of x‐ray‐based surface echo probe tracking using an attached fiducial apparatus

    by Lindsay E. Bodart, Benjamin R. Ciske, Jonathan Le, Nicole M. Reilly, Roderick C. Deaño, Steven M. Ewer, Parag Tipnis, Peter S. Rahko, Martin G. Wagner, Amish N. Raval, et al.

    Purpose Several types of structural heart intervention (SHI) use information from multiple imaging modalities to complete an interventional task. For example, in transcatheter aortic valve replacement (TAVR), placement and deployment of a bioprosthetic aortic valve in the aorta is primarily guided by x‐ray fluoroscopy (XRF), and echocardiography provides visualization of cardiac anatomy and blood flow. However, simultaneous interpretation of independent x‐ray and echo displays remains a challenge for the interventionalist. The purpose of this work was to develop a novel echo/x‐ray co‐registration solution in which volumetric transthoracic echo (TTE) is transformed to the x‐ray coordinate system by tracking the three‐dimensional (3D) pose of a probe fiducial attachment from its appearance in two‐dimensional (2D) x‐ray images. Methods A fiducial attachment for a commercial TTE probe consisting of rings of high‐contrast ball bearings was designed and fabricated. The 3D pose (position and orientation) of the fiducial attachment is estimated from a 2D x‐ray image using an algorithm in which a virtual point cloud model of the attachment is iteratively rotated, translated, and forward‐projected onto the image until the average sum‐of‐squares of grayscale values at the projected points is minimized. Fiducial registration error (FRE) and target registration error (TRE) of this approach were evaluated in phantom studies using TAVR‐relevant gantry orientations and four standard acoustic windows for the TTE probe. A patient study was conducted to assess the clinical suitability of the fiducial attachment prototype during TTE imaging of patients undergoing SHI. TTE image quality for the task of guiding a transcatheter procedure was evaluated in a reviewer study. Results The 3D FRE ranged from 0.32 ± 0.03 mm (mean ± SD) to 1.31 ± 0.05 mm, depending on C‐arm orientation and probe acoustic window. The 3D TRE ranged from 1.06 ± 0.03 mm to 2.42 ± 0.06 mm. Fiducial pose estimation was stable when >75% of the fiducial markers were visible in the x‐ray image. A panel of reviewers graded the presentation of heart valves in TTE images from 48 SHI patients. While valve presentation did not differ significantly between acoustic windows (P > 0.05), the mitral valve did achieve a significantly higher image quality compared to the aortic and tricuspid valves (P < 0.001). Overall, reviewers perceived sufficient image quality in 76.5% of images of the mitral valve, 54.9% of images of the aortic valve, and 48.6% of images of the tricuspid valve. Conclusions Fiducial‐based tracking of a commercial TTE probe is compatible with clinical SHI workflows and yields 3D target registration error of less than 2.5 mm for a variety of x‐ray gantry geometries and echo probe acoustic windows. Although TTE image quality with respect to target valve anatomy was sufficient for the majority of cases examined, prescreening of patients for sufficient TTE quality would be helpful.


  • 4D-DSA: Development and Current Neurovascular Applications

    by K.L. Ruedinger, S. Schafer, M.A. Speidel, C.M. Strother

    SUMMARY: Originally described by Davis et al in 2013, 4D-Digital Subtraction Angiography (4D-DSA) has developed into a commercially available application of DSA in the angiography suite. 4D-DSA provides the user with 3D time-resolved images, allowing observation of a contrast bolus at any desired viewing angle through the vasculature and at any time point during the acquisition (any view at any time). 4D-DSA mitigates some limitations that are intrinsic to both 2D- and 3D-DSA images. The clinical applications for 4D-DSA include evaluations of AVMs and AVFs, intracranial aneurysms, and atherosclerotic occlusive disease. Recent advances in blood flow quantification using 4D-DSA indicate that these data provide both the velocity and geometric information necessary for the quantification of blood flow. In this review, we will discuss the development, acquisition, reconstruction, and current neurovascular applications of 4D-DSA volumes.


  • Evaluation of real-time guidewire navigation using virtual endoscopic 4D fluoroscopy

    by Brian J. Davis, Martin G. Wagner, Sarvesh Periyasamy, Charles A. Mistretta, Charles M. Strother, Paul F. Laeseke, Michael A. Speidel

    4D fluoroscopy is a method for real-time 3D visualization of endovascular devices using biplane fluoroscopy. Frame-byframe (15 fps) 4D reconstructions of the device are overlayed on 3D vascular anatomy derived from 3D-DSA. We describe a 4D-assisted guidance platform that provides virtual endoscopic renderings of blood vessels and report on its use for navigating guidewires in a patient-specific vascular phantom. The 4D-assisted platform provides two 4D display modes plus conventional 2D fluoroscopy. Virtual endoscopic 4D mode shows a real-time view of the guidewire tip and the downstream vessel with a viewpoint inside the vessel. Path-planning highlights the target vessel branches. External 4D display mode provides an external rotatable viewpoint of the device and vasculature. In a phantom study, operators navigated a guidewire through branches of a 3D-printed phantom. Performance was compared to navigation with 2D fluoroscopy alone. Operators rated the degree to which they used the 2D and 4D display modes on a Likert scale (1-never, 5-almost always). Quantitative imaging metrics were obtained from processed video recordings. Three users completed 15 of 15 challenges with 4D-assisted display, whereas the 2D-only guidance completion rate was 13/15. With both 2D and 4D displays available, users reported using the 2D display never-to-sometimes (median score = 2) and 4D display often or almost always (median = 5). The virtual endoscopic viewpoint was utilized more frequently than the external viewpoint. 4D fluoroscopy with virtual endoscopic display provides a new and potentially useful mode for visualization of guidewire and catheter manipulations in complex vascular anatomy.


  • Power injector for angiographic flow analysis using custom contrast density profiles

    by Erick L. Oberstar, Sarvesh Periyasamy, Paul F. Laeseke, Michael A. Speidel

    Catheter-based vascular interventions performed in the interventional radiology suite rely heavily on digital subtraction angiography (DSA) for intraprocedural evaluation of vessel morphology. Recently, DSA methods have been reported which quantify blood flow based on the tracking of temporal oscillations in contrast agent density through vessels. This signal, termed contrast pulsatility, arises naturally from the mixing of a fixed rate contrast injection with periodic arterial blood flow. Although these tools promise quantitative intraprocedural evaluation of flow, quantification is limited by a decline in contrast pulsatility strength in distal arterial vasculature, and, in venous structures, minimally observable or no pulsatility. To improve pulsatility strength in DSA images, a custom dual-barrel power injector was constructed that dynamically modulates the injected contrast flow (or concentration). Each barrel can follow sinusoidal and square wave injection profiles of specified frequency, amplitude, phase, and duty cycle. Improvement in contrast pulsatility was evaluated in a vessel phantom with simulated 60 bpm arterial flow and low-frequency sinusoidal contrast injections of 0.25, 0.50, and 1.0Hz. The ability to establish contrast pulsatility in a venous structure was evaluated in a porcine study. In the arterial phantom, sinusoidal contrast injections at 0.25Hz, 0.5Hz, and 1.0Hz displayed increased distal contrast pulsatility relative to a DC contrast injection at the same mean rate, with energy spectral density (ESD) ratios of 215, 59.9, and 5.3 respectively. In the animal study, a custom 0.67Hz square wave injection into the inferior vena cava showed a large improvement in pulsatility relative to DC injection (ESD ratio of 7208).